Does DEFERASIROX Cause Thrombocytopenia? 152 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Thrombocytopenia have been filed in association with DEFERASIROX (Deferasirox). This represents 1.3% of all adverse event reports for DEFERASIROX.
152
Reports of Thrombocytopenia with DEFERASIROX
1.3%
of all DEFERASIROX reports
48
Deaths
85
Hospitalizations
How Dangerous Is Thrombocytopenia From DEFERASIROX?
Of the 152 reports, 48 (31.6%) resulted in death, 85 (55.9%) required hospitalization, and 20 (13.2%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFERASIROX. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does DEFERASIROX Cause?
Death (1,583)
Diarrhoea (993)
Serum ferritin increased (732)
Haemoglobin decreased (615)
Pyrexia (607)
Malaise (605)
Nausea (603)
Sickle cell anaemia with crisis (570)
Vomiting (520)
Pneumonia (494)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which DEFERASIROX Alternatives Have Lower Thrombocytopenia Risk?
DEFERASIROX vs DEFERIPRONE
DEFERASIROX vs DEFEROXAMINE
DEFERASIROX vs DEFIBROTIDE
DEFERASIROX vs DEFLAZACORT
DEFERASIROX vs DEGARELIX